nodes	percent_of_prediction	percent_of_DWPC	metapath
Tapentadol—UGT2B7—Chenodeoxycholic acid—primary biliary cirrhosis	0.698	0.918	CbGbCtD
Tapentadol—CYP2C9—Colchicine—primary biliary cirrhosis	0.0624	0.082	CbGbCtD
Tapentadol—Drug hypersensitivity—Ursodeoxycholic acid—primary biliary cirrhosis	0.00637	0.0336	CcSEcCtD
Tapentadol—Drug hypersensitivity—Chenodeoxycholic acid—primary biliary cirrhosis	0.00637	0.0336	CcSEcCtD
Tapentadol—Lung disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00363	0.0191	CcSEcCtD
Tapentadol—Lung disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00363	0.0191	CcSEcCtD
Tapentadol—Gamma-glutamyltransferase increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.00312	0.0165	CcSEcCtD
Tapentadol—Gamma-glutamyltransferase increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.00312	0.0165	CcSEcCtD
Tapentadol—Drug interaction—Ursodeoxycholic acid—primary biliary cirrhosis	0.00277	0.0146	CcSEcCtD
Tapentadol—Drug interaction—Chenodeoxycholic acid—primary biliary cirrhosis	0.00277	0.0146	CcSEcCtD
Tapentadol—Aspartate aminotransferase increased—Colchicine—primary biliary cirrhosis	0.00187	0.00985	CcSEcCtD
Tapentadol—Alanine aminotransferase increased—Colchicine—primary biliary cirrhosis	0.00183	0.00964	CcSEcCtD
Tapentadol—Abdominal discomfort—Colchicine—primary biliary cirrhosis	0.00172	0.00906	CcSEcCtD
Tapentadol—Breast disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00168	0.00888	CcSEcCtD
Tapentadol—Breast disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00168	0.00888	CcSEcCtD
Tapentadol—Aspartate aminotransferase increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.00168	0.00885	CcSEcCtD
Tapentadol—Aspartate aminotransferase increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.00168	0.00885	CcSEcCtD
Tapentadol—Alanine aminotransferase increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.00164	0.00866	CcSEcCtD
Tapentadol—Alanine aminotransferase increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.00164	0.00866	CcSEcCtD
Tapentadol—Abdominal discomfort—Chenodeoxycholic acid—primary biliary cirrhosis	0.00154	0.00814	CcSEcCtD
Tapentadol—Abdominal discomfort—Ursodeoxycholic acid—primary biliary cirrhosis	0.00154	0.00814	CcSEcCtD
Tapentadol—Upper respiratory tract infection—Ursodeoxycholic acid—primary biliary cirrhosis	0.0015	0.00789	CcSEcCtD
Tapentadol—Upper respiratory tract infection—Chenodeoxycholic acid—primary biliary cirrhosis	0.0015	0.00789	CcSEcCtD
Tapentadol—Pollakiuria—Ursodeoxycholic acid—primary biliary cirrhosis	0.00149	0.00784	CcSEcCtD
Tapentadol—Pollakiuria—Chenodeoxycholic acid—primary biliary cirrhosis	0.00149	0.00784	CcSEcCtD
Tapentadol—Weight decreased—Ursodeoxycholic acid—primary biliary cirrhosis	0.00146	0.00768	CcSEcCtD
Tapentadol—Weight decreased—Chenodeoxycholic acid—primary biliary cirrhosis	0.00146	0.00768	CcSEcCtD
Tapentadol—Infestation NOS—Ursodeoxycholic acid—primary biliary cirrhosis	0.00144	0.00757	CcSEcCtD
Tapentadol—Infestation—Ursodeoxycholic acid—primary biliary cirrhosis	0.00144	0.00757	CcSEcCtD
Tapentadol—Infestation NOS—Chenodeoxycholic acid—primary biliary cirrhosis	0.00144	0.00757	CcSEcCtD
Tapentadol—Infestation—Chenodeoxycholic acid—primary biliary cirrhosis	0.00144	0.00757	CcSEcCtD
Tapentadol—Depression—Chenodeoxycholic acid—primary biliary cirrhosis	0.00143	0.00755	CcSEcCtD
Tapentadol—Depression—Ursodeoxycholic acid—primary biliary cirrhosis	0.00143	0.00755	CcSEcCtD
Tapentadol—Hypoaesthesia—Colchicine—primary biliary cirrhosis	0.00143	0.00753	CcSEcCtD
Tapentadol—Urinary tract infection—Ursodeoxycholic acid—primary biliary cirrhosis	0.0014	0.00736	CcSEcCtD
Tapentadol—Urinary tract infection—Chenodeoxycholic acid—primary biliary cirrhosis	0.0014	0.00736	CcSEcCtD
Tapentadol—Eye disorder—Colchicine—primary biliary cirrhosis	0.00134	0.00707	CcSEcCtD
Tapentadol—Mediastinal disorder—Colchicine—primary biliary cirrhosis	0.00129	0.00682	CcSEcCtD
Tapentadol—Urinary tract disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00127	0.00671	CcSEcCtD
Tapentadol—Urinary tract disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00127	0.00671	CcSEcCtD
Tapentadol—Connective tissue disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00127	0.00668	CcSEcCtD
Tapentadol—Connective tissue disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00127	0.00668	CcSEcCtD
Tapentadol—Urethral disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00126	0.00666	CcSEcCtD
Tapentadol—Urethral disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00126	0.00666	CcSEcCtD
Tapentadol—Malnutrition—Colchicine—primary biliary cirrhosis	0.00125	0.00658	CcSEcCtD
Tapentadol—Visual impairment—Ursodeoxycholic acid—primary biliary cirrhosis	0.00124	0.00655	CcSEcCtD
Tapentadol—Visual impairment—Chenodeoxycholic acid—primary biliary cirrhosis	0.00124	0.00655	CcSEcCtD
Tapentadol—Eye disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.0012	0.00635	CcSEcCtD
Tapentadol—Eye disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.0012	0.00635	CcSEcCtD
Tapentadol—Cardiac disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.0012	0.00631	CcSEcCtD
Tapentadol—Cardiac disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.0012	0.00631	CcSEcCtD
Tapentadol—Angiopathy—Ursodeoxycholic acid—primary biliary cirrhosis	0.00117	0.00617	CcSEcCtD
Tapentadol—Angiopathy—Chenodeoxycholic acid—primary biliary cirrhosis	0.00117	0.00617	CcSEcCtD
Tapentadol—Immune system disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00116	0.00614	CcSEcCtD
Tapentadol—Immune system disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00116	0.00614	CcSEcCtD
Tapentadol—Mediastinal disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00116	0.00613	CcSEcCtD
Tapentadol—Mediastinal disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00116	0.00613	CcSEcCtD
Tapentadol—Chills—Ursodeoxycholic acid—primary biliary cirrhosis	0.00116	0.0061	CcSEcCtD
Tapentadol—Chills—Chenodeoxycholic acid—primary biliary cirrhosis	0.00116	0.0061	CcSEcCtD
Tapentadol—Angioedema—Colchicine—primary biliary cirrhosis	0.00114	0.00602	CcSEcCtD
Tapentadol—Malnutrition—Chenodeoxycholic acid—primary biliary cirrhosis	0.00112	0.00592	CcSEcCtD
Tapentadol—Malnutrition—Ursodeoxycholic acid—primary biliary cirrhosis	0.00112	0.00592	CcSEcCtD
Tapentadol—Tension—Chenodeoxycholic acid—primary biliary cirrhosis	0.0011	0.00581	CcSEcCtD
Tapentadol—Tension—Ursodeoxycholic acid—primary biliary cirrhosis	0.0011	0.00581	CcSEcCtD
Tapentadol—Nervousness—Ursodeoxycholic acid—primary biliary cirrhosis	0.00109	0.00575	CcSEcCtD
Tapentadol—Nervousness—Chenodeoxycholic acid—primary biliary cirrhosis	0.00109	0.00575	CcSEcCtD
Tapentadol—Arthralgia—Colchicine—primary biliary cirrhosis	0.00106	0.00561	CcSEcCtD
Tapentadol—Angioedema—Ursodeoxycholic acid—primary biliary cirrhosis	0.00103	0.00541	CcSEcCtD
Tapentadol—Angioedema—Chenodeoxycholic acid—primary biliary cirrhosis	0.00103	0.00541	CcSEcCtD
Tapentadol—Vertigo—Chenodeoxycholic acid—primary biliary cirrhosis	0.00101	0.00532	CcSEcCtD
Tapentadol—Vertigo—Ursodeoxycholic acid—primary biliary cirrhosis	0.00101	0.00532	CcSEcCtD
Tapentadol—Syncope—Ursodeoxycholic acid—primary biliary cirrhosis	0.00101	0.00531	CcSEcCtD
Tapentadol—Syncope—Chenodeoxycholic acid—primary biliary cirrhosis	0.00101	0.00531	CcSEcCtD
Tapentadol—Shock—Colchicine—primary biliary cirrhosis	0.001	0.00529	CcSEcCtD
Tapentadol—Nervous system disorder—Colchicine—primary biliary cirrhosis	0.000999	0.00527	CcSEcCtD
Tapentadol—Palpitations—Chenodeoxycholic acid—primary biliary cirrhosis	0.000991	0.00523	CcSEcCtD
Tapentadol—Palpitations—Ursodeoxycholic acid—primary biliary cirrhosis	0.000991	0.00523	CcSEcCtD
Tapentadol—Skin disorder—Colchicine—primary biliary cirrhosis	0.00099	0.00522	CcSEcCtD
Tapentadol—Loss of consciousness—Ursodeoxycholic acid—primary biliary cirrhosis	0.000986	0.0052	CcSEcCtD
Tapentadol—Loss of consciousness—Chenodeoxycholic acid—primary biliary cirrhosis	0.000986	0.0052	CcSEcCtD
Tapentadol—Cough—Ursodeoxycholic acid—primary biliary cirrhosis	0.000979	0.00516	CcSEcCtD
Tapentadol—Cough—Chenodeoxycholic acid—primary biliary cirrhosis	0.000979	0.00516	CcSEcCtD
Tapentadol—Convulsion—Ursodeoxycholic acid—primary biliary cirrhosis	0.000972	0.00513	CcSEcCtD
Tapentadol—Convulsion—Chenodeoxycholic acid—primary biliary cirrhosis	0.000972	0.00513	CcSEcCtD
Tapentadol—Arthralgia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000955	0.00504	CcSEcCtD
Tapentadol—Arthralgia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000955	0.00504	CcSEcCtD
Tapentadol—Hypotension—Colchicine—primary biliary cirrhosis	0.000952	0.00502	CcSEcCtD
Tapentadol—Unspecified disorder of skin and subcutaneous tissue—Ursodeoxycholic acid—primary biliary cirrhosis	0.000948	0.005	CcSEcCtD
Tapentadol—Unspecified disorder of skin and subcutaneous tissue—Chenodeoxycholic acid—primary biliary cirrhosis	0.000948	0.005	CcSEcCtD
Tapentadol—Dry mouth—Ursodeoxycholic acid—primary biliary cirrhosis	0.000934	0.00493	CcSEcCtD
Tapentadol—Dry mouth—Chenodeoxycholic acid—primary biliary cirrhosis	0.000934	0.00493	CcSEcCtD
Tapentadol—Musculoskeletal discomfort—Colchicine—primary biliary cirrhosis	0.000928	0.0049	CcSEcCtD
Tapentadol—Confusional state—Chenodeoxycholic acid—primary biliary cirrhosis	0.000923	0.00487	CcSEcCtD
Tapentadol—Confusional state—Ursodeoxycholic acid—primary biliary cirrhosis	0.000923	0.00487	CcSEcCtD
Tapentadol—Oedema—Ursodeoxycholic acid—primary biliary cirrhosis	0.000916	0.00483	CcSEcCtD
Tapentadol—Oedema—Chenodeoxycholic acid—primary biliary cirrhosis	0.000916	0.00483	CcSEcCtD
Tapentadol—Infection—Ursodeoxycholic acid—primary biliary cirrhosis	0.00091	0.0048	CcSEcCtD
Tapentadol—Infection—Chenodeoxycholic acid—primary biliary cirrhosis	0.00091	0.0048	CcSEcCtD
Tapentadol—Shock—Ursodeoxycholic acid—primary biliary cirrhosis	0.000901	0.00475	CcSEcCtD
Tapentadol—Shock—Chenodeoxycholic acid—primary biliary cirrhosis	0.000901	0.00475	CcSEcCtD
Tapentadol—Nervous system disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000898	0.00474	CcSEcCtD
Tapentadol—Nervous system disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000898	0.00474	CcSEcCtD
Tapentadol—Tachycardia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000894	0.00471	CcSEcCtD
Tapentadol—Tachycardia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000894	0.00471	CcSEcCtD
Tapentadol—Skin disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000889	0.00469	CcSEcCtD
Tapentadol—Skin disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000889	0.00469	CcSEcCtD
Tapentadol—Decreased appetite—Colchicine—primary biliary cirrhosis	0.000886	0.00467	CcSEcCtD
Tapentadol—Hyperhidrosis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000885	0.00467	CcSEcCtD
Tapentadol—Hyperhidrosis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000885	0.00467	CcSEcCtD
Tapentadol—Gastrointestinal disorder—Colchicine—primary biliary cirrhosis	0.00088	0.00464	CcSEcCtD
Tapentadol—Fatigue—Colchicine—primary biliary cirrhosis	0.000879	0.00463	CcSEcCtD
Tapentadol—Hypotension—Ursodeoxycholic acid—primary biliary cirrhosis	0.000856	0.00451	CcSEcCtD
Tapentadol—Hypotension—Chenodeoxycholic acid—primary biliary cirrhosis	0.000856	0.00451	CcSEcCtD
Tapentadol—Musculoskeletal discomfort—Chenodeoxycholic acid—primary biliary cirrhosis	0.000834	0.0044	CcSEcCtD
Tapentadol—Musculoskeletal discomfort—Ursodeoxycholic acid—primary biliary cirrhosis	0.000834	0.0044	CcSEcCtD
Tapentadol—Insomnia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000828	0.00437	CcSEcCtD
Tapentadol—Insomnia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000828	0.00437	CcSEcCtD
Tapentadol—Paraesthesia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000822	0.00434	CcSEcCtD
Tapentadol—Paraesthesia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000822	0.00434	CcSEcCtD
Tapentadol—Dyspnoea—Ursodeoxycholic acid—primary biliary cirrhosis	0.000816	0.0043	CcSEcCtD
Tapentadol—Dyspnoea—Chenodeoxycholic acid—primary biliary cirrhosis	0.000816	0.0043	CcSEcCtD
Tapentadol—Somnolence—Chenodeoxycholic acid—primary biliary cirrhosis	0.000814	0.00429	CcSEcCtD
Tapentadol—Somnolence—Ursodeoxycholic acid—primary biliary cirrhosis	0.000814	0.00429	CcSEcCtD
Tapentadol—Urticaria—Colchicine—primary biliary cirrhosis	0.000809	0.00427	CcSEcCtD
Tapentadol—Dyspepsia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000806	0.00425	CcSEcCtD
Tapentadol—Dyspepsia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000806	0.00425	CcSEcCtD
Tapentadol—Decreased appetite—Ursodeoxycholic acid—primary biliary cirrhosis	0.000796	0.0042	CcSEcCtD
Tapentadol—Decreased appetite—Chenodeoxycholic acid—primary biliary cirrhosis	0.000796	0.0042	CcSEcCtD
Tapentadol—Gastrointestinal disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00079	0.00417	CcSEcCtD
Tapentadol—Gastrointestinal disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00079	0.00417	CcSEcCtD
Tapentadol—Fatigue—Ursodeoxycholic acid—primary biliary cirrhosis	0.000789	0.00416	CcSEcCtD
Tapentadol—Fatigue—Chenodeoxycholic acid—primary biliary cirrhosis	0.000789	0.00416	CcSEcCtD
Tapentadol—Constipation—Chenodeoxycholic acid—primary biliary cirrhosis	0.000783	0.00413	CcSEcCtD
Tapentadol—Constipation—Ursodeoxycholic acid—primary biliary cirrhosis	0.000783	0.00413	CcSEcCtD
Tapentadol—Feeling abnormal—Ursodeoxycholic acid—primary biliary cirrhosis	0.000754	0.00398	CcSEcCtD
Tapentadol—Feeling abnormal—Chenodeoxycholic acid—primary biliary cirrhosis	0.000754	0.00398	CcSEcCtD
Tapentadol—Hypersensitivity—Colchicine—primary biliary cirrhosis	0.000751	0.00396	CcSEcCtD
Tapentadol—Asthenia—Colchicine—primary biliary cirrhosis	0.000731	0.00386	CcSEcCtD
Tapentadol—Urticaria—Chenodeoxycholic acid—primary biliary cirrhosis	0.000727	0.00384	CcSEcCtD
Tapentadol—Urticaria—Ursodeoxycholic acid—primary biliary cirrhosis	0.000727	0.00384	CcSEcCtD
Tapentadol—Diarrhoea—Colchicine—primary biliary cirrhosis	0.000697	0.00368	CcSEcCtD
Tapentadol—Hypersensitivity—Chenodeoxycholic acid—primary biliary cirrhosis	0.000675	0.00356	CcSEcCtD
Tapentadol—Hypersensitivity—Ursodeoxycholic acid—primary biliary cirrhosis	0.000675	0.00356	CcSEcCtD
Tapentadol—Asthenia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000657	0.00346	CcSEcCtD
Tapentadol—Asthenia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000657	0.00346	CcSEcCtD
Tapentadol—Vomiting—Colchicine—primary biliary cirrhosis	0.000648	0.00342	CcSEcCtD
Tapentadol—Pruritus—Ursodeoxycholic acid—primary biliary cirrhosis	0.000648	0.00342	CcSEcCtD
Tapentadol—Pruritus—Chenodeoxycholic acid—primary biliary cirrhosis	0.000648	0.00342	CcSEcCtD
Tapentadol—Rash—Colchicine—primary biliary cirrhosis	0.000642	0.00339	CcSEcCtD
Tapentadol—Dermatitis—Colchicine—primary biliary cirrhosis	0.000642	0.00339	CcSEcCtD
Tapentadol—Headache—Colchicine—primary biliary cirrhosis	0.000638	0.00337	CcSEcCtD
Tapentadol—Diarrhoea—Chenodeoxycholic acid—primary biliary cirrhosis	0.000626	0.0033	CcSEcCtD
Tapentadol—Diarrhoea—Ursodeoxycholic acid—primary biliary cirrhosis	0.000626	0.0033	CcSEcCtD
Tapentadol—Dizziness—Chenodeoxycholic acid—primary biliary cirrhosis	0.000605	0.00319	CcSEcCtD
Tapentadol—Dizziness—Ursodeoxycholic acid—primary biliary cirrhosis	0.000605	0.00319	CcSEcCtD
Tapentadol—Nausea—Colchicine—primary biliary cirrhosis	0.000605	0.00319	CcSEcCtD
Tapentadol—Vomiting—Ursodeoxycholic acid—primary biliary cirrhosis	0.000582	0.00307	CcSEcCtD
Tapentadol—Vomiting—Chenodeoxycholic acid—primary biliary cirrhosis	0.000582	0.00307	CcSEcCtD
Tapentadol—Rash—Ursodeoxycholic acid—primary biliary cirrhosis	0.000577	0.00304	CcSEcCtD
Tapentadol—Rash—Chenodeoxycholic acid—primary biliary cirrhosis	0.000577	0.00304	CcSEcCtD
Tapentadol—Dermatitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000577	0.00304	CcSEcCtD
Tapentadol—Dermatitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000577	0.00304	CcSEcCtD
Tapentadol—Headache—Ursodeoxycholic acid—primary biliary cirrhosis	0.000574	0.00302	CcSEcCtD
Tapentadol—Headache—Chenodeoxycholic acid—primary biliary cirrhosis	0.000574	0.00302	CcSEcCtD
Tapentadol—Nausea—Ursodeoxycholic acid—primary biliary cirrhosis	0.000544	0.00287	CcSEcCtD
Tapentadol—Nausea—Chenodeoxycholic acid—primary biliary cirrhosis	0.000544	0.00287	CcSEcCtD
Tapentadol—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCL9—primary biliary cirrhosis	0.000207	0.00419	CbGpPWpGaD
Tapentadol—UGT1A9—PPARA activates gene expression—PPARGC1A—primary biliary cirrhosis	0.000199	0.00402	CbGpPWpGaD
Tapentadol—OPRD1—GPCR ligand binding—CXCR5—primary biliary cirrhosis	0.000198	0.00401	CbGpPWpGaD
Tapentadol—CYP2C19—Arachidonic acid metabolism—GGT1—primary biliary cirrhosis	0.000197	0.00399	CbGpPWpGaD
Tapentadol—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARGC1A—primary biliary cirrhosis	0.000195	0.00394	CbGpPWpGaD
Tapentadol—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCR5—primary biliary cirrhosis	0.000193	0.0039	CbGpPWpGaD
Tapentadol—UGT2B7—Biological oxidations—GGT1—primary biliary cirrhosis	0.000192	0.00389	CbGpPWpGaD
Tapentadol—SLC6A2—NRF2 pathway—GGT1—primary biliary cirrhosis	0.000186	0.00376	CbGpPWpGaD
Tapentadol—HTR3A—Transmembrane transport of small molecules—AQP4—primary biliary cirrhosis	0.000185	0.00375	CbGpPWpGaD
Tapentadol—OPRD1—Peptide ligand-binding receptors—CXCL10—primary biliary cirrhosis	0.000183	0.00371	CbGpPWpGaD
Tapentadol—SLC6A4—SIDS Susceptibility Pathways—PPARGC1A—primary biliary cirrhosis	0.000182	0.00369	CbGpPWpGaD
Tapentadol—CYP2C9—Arachidonic acid metabolism—GGT1—primary biliary cirrhosis	0.00018	0.00364	CbGpPWpGaD
Tapentadol—OPRD1—GPCR ligand binding—CXCL9—primary biliary cirrhosis	0.00018	0.00364	CbGpPWpGaD
Tapentadol—UGT1A9—NRF2 pathway—GGT1—primary biliary cirrhosis	0.000178	0.00361	CbGpPWpGaD
Tapentadol—HTR3A—Transmembrane transport of small molecules—ABCC2—primary biliary cirrhosis	0.000177	0.00359	CbGpPWpGaD
Tapentadol—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—CTGF—primary biliary cirrhosis	0.000176	0.00356	CbGpPWpGaD
Tapentadol—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL9—primary biliary cirrhosis	0.000175	0.00354	CbGpPWpGaD
Tapentadol—OPRK1—GPCR ligand binding—CXCR5—primary biliary cirrhosis	0.000174	0.00351	CbGpPWpGaD
Tapentadol—SLC6A2—SLC-mediated transmembrane transport—NUP210—primary biliary cirrhosis	0.000171	0.00347	CbGpPWpGaD
Tapentadol—HTR3A—Transmembrane transport of small molecules—NUP210—primary biliary cirrhosis	0.000162	0.00328	CbGpPWpGaD
Tapentadol—OPRK1—Peptide ligand-binding receptors—CXCL10—primary biliary cirrhosis	0.000161	0.00325	CbGpPWpGaD
Tapentadol—OPRD1—Peptide ligand-binding receptors—CCL5—primary biliary cirrhosis	0.000158	0.00319	CbGpPWpGaD
Tapentadol—OPRK1—GPCR ligand binding—CXCL9—primary biliary cirrhosis	0.000158	0.00319	CbGpPWpGaD
Tapentadol—UGT1A9—Biological oxidations—GGT1—primary biliary cirrhosis	0.000156	0.00316	CbGpPWpGaD
Tapentadol—UGT1A9—PPARA activates gene expression—AGT—primary biliary cirrhosis	0.000155	0.00313	CbGpPWpGaD
Tapentadol—OPRD1—G alpha (i) signalling events—CXCL10—primary biliary cirrhosis	0.000155	0.00313	CbGpPWpGaD
Tapentadol—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—AGT—primary biliary cirrhosis	0.000152	0.00307	CbGpPWpGaD
Tapentadol—HTR3A—Transmembrane transport of small molecules—ABCG2—primary biliary cirrhosis	0.000151	0.00305	CbGpPWpGaD
Tapentadol—SLC6A4—Circadian rythm related genes—PPARGC1A—primary biliary cirrhosis	0.000149	0.00301	CbGpPWpGaD
Tapentadol—OPRM1—GPCR ligand binding—CXCR5—primary biliary cirrhosis	0.000147	0.00297	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism of lipids and lipoproteins—ABCB4—primary biliary cirrhosis	0.000146	0.00296	CbGpPWpGaD
Tapentadol—SLC6A4—SIDS Susceptibility Pathways—HIF1A—primary biliary cirrhosis	0.000142	0.00288	CbGpPWpGaD
Tapentadol—OPRK1—Peptide ligand-binding receptors—CCL5—primary biliary cirrhosis	0.000138	0.0028	CbGpPWpGaD
Tapentadol—OPRM1—Peptide ligand-binding receptors—CXCL10—primary biliary cirrhosis	0.000136	0.00275	CbGpPWpGaD
Tapentadol—OPRK1—G alpha (i) signalling events—CXCL10—primary biliary cirrhosis	0.000136	0.00274	CbGpPWpGaD
Tapentadol—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—PPARGC1A—primary biliary cirrhosis	0.000134	0.00271	CbGpPWpGaD
Tapentadol—OPRM1—GPCR ligand binding—CXCL9—primary biliary cirrhosis	0.000133	0.0027	CbGpPWpGaD
Tapentadol—OPRD1—G alpha (i) signalling events—CCL5—primary biliary cirrhosis	0.000133	0.00269	CbGpPWpGaD
Tapentadol—HTR3A—SIDS Susceptibility Pathways—NFKB1—primary biliary cirrhosis	0.000132	0.00268	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—LBR—primary biliary cirrhosis	0.000132	0.00268	CbGpPWpGaD
Tapentadol—OPRD1—Peptide ligand-binding receptors—AGT—primary biliary cirrhosis	0.000132	0.00267	CbGpPWpGaD
Tapentadol—CYP2C19—Melatonin metabolism and effects—NFKB1—primary biliary cirrhosis	0.000123	0.00249	CbGpPWpGaD
Tapentadol—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCL10—primary biliary cirrhosis	0.000123	0.00249	CbGpPWpGaD
Tapentadol—OPRM1—Peptide ligand-binding receptors—CCL5—primary biliary cirrhosis	0.000117	0.00237	CbGpPWpGaD
Tapentadol—OPRK1—G alpha (i) signalling events—CCL5—primary biliary cirrhosis	0.000117	0.00236	CbGpPWpGaD
Tapentadol—OPRK1—Peptide ligand-binding receptors—AGT—primary biliary cirrhosis	0.000116	0.00234	CbGpPWpGaD
Tapentadol—OPRM1—G alpha (i) signalling events—CXCL10—primary biliary cirrhosis	0.000115	0.00232	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism of lipids and lipoproteins—LBR—primary biliary cirrhosis	0.000114	0.0023	CbGpPWpGaD
Tapentadol—CYP2D6—Melatonin metabolism and effects—NFKB1—primary biliary cirrhosis	0.000113	0.00229	CbGpPWpGaD
Tapentadol—OPRD1—GPCR downstream signaling—CXCR5—primary biliary cirrhosis	0.000112	0.00226	CbGpPWpGaD
Tapentadol—OPRD1—G alpha (i) signalling events—AGT—primary biliary cirrhosis	0.000111	0.00225	CbGpPWpGaD
Tapentadol—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCL10—primary biliary cirrhosis	0.000108	0.00218	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—LBR—primary biliary cirrhosis	0.000108	0.00218	CbGpPWpGaD
Tapentadol—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCL5—primary biliary cirrhosis	0.000106	0.00214	CbGpPWpGaD
Tapentadol—SLC6A4—Circadian rythm related genes—NOS2—primary biliary cirrhosis	0.000106	0.00214	CbGpPWpGaD
Tapentadol—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—AGT—primary biliary cirrhosis	0.000104	0.00211	CbGpPWpGaD
Tapentadol—OPRM1—TCR Signaling Pathway—NFKB1—primary biliary cirrhosis	0.000104	0.0021	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—LBR—primary biliary cirrhosis	0.000104	0.00209	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—CXCR5—primary biliary cirrhosis	0.000102	0.00206	CbGpPWpGaD
Tapentadol—OPRD1—GPCR downstream signaling—CXCL9—primary biliary cirrhosis	0.000102	0.00206	CbGpPWpGaD
Tapentadol—SLC6A2—Transmembrane transport of small molecules—AQP4—primary biliary cirrhosis	9.94e-05	0.00201	CbGpPWpGaD
Tapentadol—OPRM1—G alpha (i) signalling events—CCL5—primary biliary cirrhosis	9.87e-05	0.002	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—CXCR5—primary biliary cirrhosis	9.81e-05	0.00199	CbGpPWpGaD
Tapentadol—OPRM1—Peptide ligand-binding receptors—AGT—primary biliary cirrhosis	9.78e-05	0.00198	CbGpPWpGaD
Tapentadol—OPRK1—G alpha (i) signalling events—AGT—primary biliary cirrhosis	9.76e-05	0.00198	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—OGDH—primary biliary cirrhosis	9.57e-05	0.00194	CbGpPWpGaD
Tapentadol—SLC6A2—Transmembrane transport of small molecules—ABCC2—primary biliary cirrhosis	9.53e-05	0.00193	CbGpPWpGaD
Tapentadol—OPRD1—GPCR ligand binding—CXCL10—primary biliary cirrhosis	9.36e-05	0.00189	CbGpPWpGaD
Tapentadol—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCL5—primary biliary cirrhosis	9.28e-05	0.00188	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—CXCL9—primary biliary cirrhosis	9.23e-05	0.00187	CbGpPWpGaD
Tapentadol—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL10—primary biliary cirrhosis	9.11e-05	0.00184	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—CXCR5—primary biliary cirrhosis	8.91e-05	0.0018	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—CXCL9—primary biliary cirrhosis	8.91e-05	0.0018	CbGpPWpGaD
Tapentadol—OPRD1—Class A/1 (Rhodopsin-like receptors)—AGT—primary biliary cirrhosis	8.85e-05	0.00179	CbGpPWpGaD
Tapentadol—SLC6A2—Transmembrane transport of small molecules—NUP210—primary biliary cirrhosis	8.71e-05	0.00176	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—PDHX—primary biliary cirrhosis	8.53e-05	0.00173	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—CXCR5—primary biliary cirrhosis	8.29e-05	0.00168	CbGpPWpGaD
Tapentadol—SLC6A4—SIDS Susceptibility Pathways—NFKB1—primary biliary cirrhosis	8.27e-05	0.00167	CbGpPWpGaD
Tapentadol—OPRM1—G alpha (i) signalling events—AGT—primary biliary cirrhosis	8.25e-05	0.00167	CbGpPWpGaD
Tapentadol—OPRK1—GPCR ligand binding—CXCL10—primary biliary cirrhosis	8.21e-05	0.00166	CbGpPWpGaD
Tapentadol—SLC6A2—Transmembrane transport of small molecules—ABCG2—primary biliary cirrhosis	8.1e-05	0.00164	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—CXCL9—primary biliary cirrhosis	8.09e-05	0.00164	CbGpPWpGaD
Tapentadol—OPRD1—GPCR ligand binding—CCL5—primary biliary cirrhosis	8.06e-05	0.00163	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—DLAT—primary biliary cirrhosis	8.02e-05	0.00162	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—ABCB4—primary biliary cirrhosis	8.02e-05	0.00162	CbGpPWpGaD
Tapentadol—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL5—primary biliary cirrhosis	7.84e-05	0.00159	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—OGDH—primary biliary cirrhosis	7.78e-05	0.00157	CbGpPWpGaD
Tapentadol—OPRK1—Class A/1 (Rhodopsin-like receptors)—AGT—primary biliary cirrhosis	7.76e-05	0.00157	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—CXCR5—primary biliary cirrhosis	7.53e-05	0.00152	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—CXCL9—primary biliary cirrhosis	7.53e-05	0.00152	CbGpPWpGaD
Tapentadol—CYP2C19—Biological oxidations—GGT1—primary biliary cirrhosis	7.35e-05	0.00149	CbGpPWpGaD
Tapentadol—OPRK1—GPCR ligand binding—CCL5—primary biliary cirrhosis	7.07e-05	0.00143	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism of lipids and lipoproteins—CTGF—primary biliary cirrhosis	7.02e-05	0.00142	CbGpPWpGaD
Tapentadol—OPRM1—GPCR ligand binding—CXCL10—primary biliary cirrhosis	6.94e-05	0.0014	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—PDHX—primary biliary cirrhosis	6.93e-05	0.0014	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism of lipids and lipoproteins—ABCB4—primary biliary cirrhosis	6.88e-05	0.00139	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—CXCL9—primary biliary cirrhosis	6.84e-05	0.00138	CbGpPWpGaD
Tapentadol—CYP2D6—Biological oxidations—GGT1—primary biliary cirrhosis	6.76e-05	0.00137	CbGpPWpGaD
Tapentadol—OPRD1—GPCR ligand binding—AGT—primary biliary cirrhosis	6.74e-05	0.00136	CbGpPWpGaD
Tapentadol—CYP2C9—Biological oxidations—GGT1—primary biliary cirrhosis	6.7e-05	0.00136	CbGpPWpGaD
Tapentadol—OPRM1—Class A/1 (Rhodopsin-like receptors)—AGT—primary biliary cirrhosis	6.56e-05	0.00133	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—DLAT—primary biliary cirrhosis	6.52e-05	0.00132	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—ABCB4—primary biliary cirrhosis	6.52e-05	0.00132	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—ABCB4—primary biliary cirrhosis	6.27e-05	0.00127	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—CDH5—primary biliary cirrhosis	6.23e-05	0.00126	CbGpPWpGaD
Tapentadol—SLC6A2—SLC-mediated transmembrane transport—ALB—primary biliary cirrhosis	6.22e-05	0.00126	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—CXCR5—primary biliary cirrhosis	6e-05	0.00121	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism of lipids and lipoproteins—GGT1—primary biliary cirrhosis	6e-05	0.00121	CbGpPWpGaD
Tapentadol—OPRM1—GPCR ligand binding—CCL5—primary biliary cirrhosis	5.97e-05	0.00121	CbGpPWpGaD
Tapentadol—OPRK1—GPCR ligand binding—AGT—primary biliary cirrhosis	5.91e-05	0.0012	CbGpPWpGaD
Tapentadol—HTR3A—Transmembrane transport of small molecules—ALB—primary biliary cirrhosis	5.89e-05	0.00119	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—CDH5—primary biliary cirrhosis	5.47e-05	0.00111	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—CXCL9—primary biliary cirrhosis	5.45e-05	0.0011	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism of lipids and lipoproteins—PPARGC1A—primary biliary cirrhosis	5.34e-05	0.00108	CbGpPWpGaD
Tapentadol—OPRD1—GPCR downstream signaling—CXCL10—primary biliary cirrhosis	5.29e-05	0.00107	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—CXCR5—primary biliary cirrhosis	5.26e-05	0.00106	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—LBR—primary biliary cirrhosis	5.06e-05	0.00102	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—ELMO1—primary biliary cirrhosis	5.04e-05	0.00102	CbGpPWpGaD
Tapentadol—OPRM1—GPCR ligand binding—AGT—primary biliary cirrhosis	5e-05	0.00101	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—NUP210—primary biliary cirrhosis	4.82e-05	0.000975	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—CXCL10—primary biliary cirrhosis	4.81e-05	0.000972	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—CXCL9—primary biliary cirrhosis	4.78e-05	0.000967	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—LBR—primary biliary cirrhosis	4.65e-05	0.000941	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—CXCL10—primary biliary cirrhosis	4.64e-05	0.000939	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—CDH5—primary biliary cirrhosis	4.62e-05	0.000935	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—LBR—primary biliary cirrhosis	4.61e-05	0.000933	CbGpPWpGaD
Tapentadol—OPRD1—GPCR downstream signaling—CCL5—primary biliary cirrhosis	4.55e-05	0.000922	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—ABCG2—primary biliary cirrhosis	4.48e-05	0.000907	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—CXCR5—primary biliary cirrhosis	4.45e-05	0.0009	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—ELMO1—primary biliary cirrhosis	4.42e-05	0.000895	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—MMP3—primary biliary cirrhosis	4.38e-05	0.000887	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—CXCL10—primary biliary cirrhosis	4.21e-05	0.000853	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism of lipids and lipoproteins—AGT—primary biliary cirrhosis	4.16e-05	0.000842	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—CCL5—primary biliary cirrhosis	4.14e-05	0.000837	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—CXCL9—primary biliary cirrhosis	4.04e-05	0.000817	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—CCL5—primary biliary cirrhosis	3.99e-05	0.000808	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—CXCL10—primary biliary cirrhosis	3.92e-05	0.000793	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—NUP210—primary biliary cirrhosis	3.92e-05	0.000793	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—CTGF—primary biliary cirrhosis	3.84e-05	0.000778	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—MMP3—primary biliary cirrhosis	3.84e-05	0.000778	CbGpPWpGaD
Tapentadol—OPRD1—GPCR downstream signaling—AGT—primary biliary cirrhosis	3.81e-05	0.000771	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—GOT2—primary biliary cirrhosis	3.81e-05	0.000771	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—ELMO1—primary biliary cirrhosis	3.74e-05	0.000756	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—OGDH—primary biliary cirrhosis	3.66e-05	0.00074	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—ABCG2—primary biliary cirrhosis	3.64e-05	0.000737	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—CCL5—primary biliary cirrhosis	3.63e-05	0.000734	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—CXCL10—primary biliary cirrhosis	3.56e-05	0.000721	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—AGT—primary biliary cirrhosis	3.46e-05	0.0007	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—CCL5—primary biliary cirrhosis	3.38e-05	0.000683	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—OGDH—primary biliary cirrhosis	3.36e-05	0.00068	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—AGT—primary biliary cirrhosis	3.34e-05	0.000676	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—OGDH—primary biliary cirrhosis	3.33e-05	0.000674	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—primary biliary cirrhosis	3.3e-05	0.000667	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—GOT1—primary biliary cirrhosis	3.29e-05	0.000666	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—GGT1—primary biliary cirrhosis	3.29e-05	0.000666	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—PDHX—primary biliary cirrhosis	3.26e-05	0.000659	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—MMP3—primary biliary cirrhosis	3.25e-05	0.000657	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism of lipids and lipoproteins—ALB—primary biliary cirrhosis	3.19e-05	0.000646	CbGpPWpGaD
Tapentadol—SLC6A2—Transmembrane transport of small molecules—ALB—primary biliary cirrhosis	3.16e-05	0.00064	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—CTGF—primary biliary cirrhosis	3.12e-05	0.000632	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—GOT2—primary biliary cirrhosis	3.1e-05	0.000627	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—CCL5—primary biliary cirrhosis	3.07e-05	0.00062	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—ABCB4—primary biliary cirrhosis	3.06e-05	0.00062	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—DLAT—primary biliary cirrhosis	3.06e-05	0.00062	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—AGT—primary biliary cirrhosis	3.03e-05	0.000614	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—primary biliary cirrhosis	3.01e-05	0.000608	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—PDHX—primary biliary cirrhosis	3e-05	0.000606	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—PDHX—primary biliary cirrhosis	2.97e-05	0.000601	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—PPARGC1A—primary biliary cirrhosis	2.93e-05	0.000592	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—CXCL10—primary biliary cirrhosis	2.84e-05	0.000574	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—AGT—primary biliary cirrhosis	2.82e-05	0.000571	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism of lipids and lipoproteins—GGT1—primary biliary cirrhosis	2.82e-05	0.000571	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—DLAT—primary biliary cirrhosis	2.82e-05	0.00057	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—ABCB4—primary biliary cirrhosis	2.82e-05	0.00057	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—DLAT—primary biliary cirrhosis	2.79e-05	0.000565	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—ABCB4—primary biliary cirrhosis	2.79e-05	0.000565	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—GOT1—primary biliary cirrhosis	2.67e-05	0.000541	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—GGT1—primary biliary cirrhosis	2.67e-05	0.000541	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—MMP3—primary biliary cirrhosis	2.59e-05	0.000524	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—TYK2—primary biliary cirrhosis	2.59e-05	0.000524	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—primary biliary cirrhosis	2.57e-05	0.00052	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—AGT—primary biliary cirrhosis	2.56e-05	0.000519	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism of lipids and lipoproteins—PPARGC1A—primary biliary cirrhosis	2.51e-05	0.000508	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—CXCL10—primary biliary cirrhosis	2.49e-05	0.000504	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—CCL5—primary biliary cirrhosis	2.44e-05	0.000494	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—PPARGC1A—primary biliary cirrhosis	2.38e-05	0.000481	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	2.37e-05	0.000479	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—PPARGC1A—primary biliary cirrhosis	2.29e-05	0.000463	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—AGT—primary biliary cirrhosis	2.28e-05	0.000461	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—MMP3—primary biliary cirrhosis	2.27e-05	0.000459	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—TYK2—primary biliary cirrhosis	2.27e-05	0.000459	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—CCL5—primary biliary cirrhosis	2.14e-05	0.000434	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—CXCL10—primary biliary cirrhosis	2.1e-05	0.000426	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	2.08e-05	0.00042	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—HIF1A—primary biliary cirrhosis	2.05e-05	0.000415	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—AGT—primary biliary cirrhosis	2.04e-05	0.000414	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism of lipids and lipoproteins—AGT—primary biliary cirrhosis	1.96e-05	0.000396	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—MMP3—primary biliary cirrhosis	1.92e-05	0.000388	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—TYK2—primary biliary cirrhosis	1.92e-05	0.000388	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—AGT—primary biliary cirrhosis	1.85e-05	0.000375	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—NUP210—primary biliary cirrhosis	1.84e-05	0.000373	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—CCL5—primary biliary cirrhosis	1.81e-05	0.000366	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—CD80—primary biliary cirrhosis	1.81e-05	0.000366	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—HIF1A—primary biliary cirrhosis	1.8e-05	0.000364	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—AGT—primary biliary cirrhosis	1.79e-05	0.000363	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—AGT—primary biliary cirrhosis	1.78e-05	0.000361	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	1.75e-05	0.000355	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—ALB—primary biliary cirrhosis	1.75e-05	0.000354	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—ABCG2—primary biliary cirrhosis	1.71e-05	0.000346	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—NUP210—primary biliary cirrhosis	1.69e-05	0.000343	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—NUP210—primary biliary cirrhosis	1.68e-05	0.00034	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—CD80—primary biliary cirrhosis	1.59e-05	0.000321	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—ABCG2—primary biliary cirrhosis	1.57e-05	0.000319	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—ABCG2—primary biliary cirrhosis	1.56e-05	0.000316	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—TYK2—primary biliary cirrhosis	1.53e-05	0.000309	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—HIF1A—primary biliary cirrhosis	1.52e-05	0.000308	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—AGT—primary biliary cirrhosis	1.51e-05	0.000307	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism of lipids and lipoproteins—ALB—primary biliary cirrhosis	1.5e-05	0.000304	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—CTGF—primary biliary cirrhosis	1.47e-05	0.000297	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—GOT2—primary biliary cirrhosis	1.46e-05	0.000294	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—ALB—primary biliary cirrhosis	1.42e-05	0.000288	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—ALB—primary biliary cirrhosis	1.37e-05	0.000277	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—CTGF—primary biliary cirrhosis	1.35e-05	0.000273	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—CD80—primary biliary cirrhosis	1.34e-05	0.000272	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—TYK2—primary biliary cirrhosis	1.34e-05	0.000271	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—CTGF—primary biliary cirrhosis	1.34e-05	0.000271	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—GOT2—primary biliary cirrhosis	1.34e-05	0.000271	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—GOT2—primary biliary cirrhosis	1.33e-05	0.000268	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—GGT1—primary biliary cirrhosis	1.26e-05	0.000254	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—GOT1—primary biliary cirrhosis	1.26e-05	0.000254	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—MMP9—primary biliary cirrhosis	1.2e-05	0.000244	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—NFKB1—primary biliary cirrhosis	1.19e-05	0.000241	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—GOT1—primary biliary cirrhosis	1.16e-05	0.000234	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—GGT1—primary biliary cirrhosis	1.16e-05	0.000234	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—GGT1—primary biliary cirrhosis	1.15e-05	0.000232	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—GOT1—primary biliary cirrhosis	1.15e-05	0.000232	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—TYK2—primary biliary cirrhosis	1.13e-05	0.000229	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—PPARGC1A—primary biliary cirrhosis	1.12e-05	0.000226	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—MMP9—primary biliary cirrhosis	1.06e-05	0.000214	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—NFKB1—primary biliary cirrhosis	1.04e-05	0.000211	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—PPARGC1A—primary biliary cirrhosis	1.03e-05	0.000208	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—PPARGC1A—primary biliary cirrhosis	1.02e-05	0.000206	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—MMP9—primary biliary cirrhosis	8.92e-06	0.000181	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—NFKB1—primary biliary cirrhosis	8.83e-06	0.000179	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—AGT—primary biliary cirrhosis	8.71e-06	0.000176	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—AGT—primary biliary cirrhosis	8.01e-06	0.000162	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—AGT—primary biliary cirrhosis	7.94e-06	0.000161	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—ALB—primary biliary cirrhosis	6.68e-06	0.000135	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—ALB—primary biliary cirrhosis	6.15e-06	0.000124	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—ALB—primary biliary cirrhosis	6.09e-06	0.000123	CbGpPWpGaD
